Related Experiment Video
Updated: Jan 13, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Chronic Hepatitis B: Current Management and Future Directions
Hamza Ertugrul1, Esra Ekiz1, Sibel Islak Mutcali2
1Trinity Health of New England, St. Mary's Hospital, 56 Franklin Street, Waterbury, CT 06706, USA.
Insights
Chronic hepatitis B (CHB) management faces challenges due to persistent virus, despite existing treatments. New therapies aim for a functional cure by targeting viral reservoirs and enhancing immunity.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Chronic hepatitis B virus (HBV) infection is a significant global health issue causing liver disease.
- Current treatments like nucleos(t)ide analogs and interferon suppress HBV but do not offer a cure.
- Persistent covalently closed circular DNA (cccDNA) prevents complete viral eradication.
Purpose of the Study:
- To review current therapeutic strategies for chronic hepatitis B (CHB).
- To summarize recent advancements in CHB treatment.
- To explore emerging directions for achieving a functional cure for CHB.
Main Methods:
- Literature review of current and emerging CHB therapies.
- Analysis of research on novel antiviral agents and immunomodulatory treatments.
- Synthesis of data on combination strategies for HBV management.
Main Results:
- Existing therapies improve viral suppression and delay disease progression.
- Novel agents and immunotherapies show promise in research settings.
- Combination strategies are being investigated for enhanced efficacy.
Conclusions:
- A functional cure for CHB remains a key goal.
- New therapeutic avenues are crucial for overcoming treatment limitations.
- Continued research into novel agents and combination therapies is essential for advancing CHB management.
Abstract:
Chronic hepatitis B virus (HBV) infection remains a major global health burden, affecting millions and contributing significantly to liver-related morbidity and mortality. While substantial progress has been made in elucidating the virology and natural history of HBV, the management of chronic hepatitis B (CHB) continues to present clinical challenges. The development of potent nucleos(t)ide analogs and pegylated interferon has improved viral suppression and delayed disease progression, yet a definitive cure remains elusive due to the persistence of covalently closed circular DNA (cccDNA). Recent research has focused on novel antiviral agents, immunomodulatory therapies, and combination strategies aimed at achieving a functional cure. This review summarizes current therapeutic approaches, recent advancements, and emerging directions in CHB management.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management
Myocarditis IV: Nursing Management
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test